1. Home
  2. COEP vs CIIT Comparison

COEP vs CIIT Comparison

Compare COEP & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CIIT
  • Stock Information
  • Founded
  • COEP 2017
  • CIIT N/A
  • Country
  • COEP United States
  • CIIT Hong Kong
  • Employees
  • COEP N/A
  • CIIT N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CIIT
  • Sector
  • COEP Health Care
  • CIIT
  • Exchange
  • COEP Nasdaq
  • CIIT NYSE
  • Market Cap
  • COEP 32.0M
  • CIIT 34.6M
  • IPO Year
  • COEP N/A
  • CIIT N/A
  • Fundamental
  • Price
  • COEP $8.03
  • CIIT $2.01
  • Analyst Decision
  • COEP
  • CIIT
  • Analyst Count
  • COEP 0
  • CIIT 0
  • Target Price
  • COEP N/A
  • CIIT N/A
  • AVG Volume (30 Days)
  • COEP 25.9K
  • CIIT 170.3K
  • Earning Date
  • COEP 08-15-2025
  • CIIT 06-09-2025
  • Dividend Yield
  • COEP N/A
  • CIIT N/A
  • EPS Growth
  • COEP N/A
  • CIIT N/A
  • EPS
  • COEP N/A
  • CIIT N/A
  • Revenue
  • COEP $62,874.00
  • CIIT $9,464,501.00
  • Revenue This Year
  • COEP N/A
  • CIIT N/A
  • Revenue Next Year
  • COEP N/A
  • CIIT N/A
  • P/E Ratio
  • COEP N/A
  • CIIT N/A
  • Revenue Growth
  • COEP N/A
  • CIIT 51.52
  • 52 Week Low
  • COEP $2.31
  • CIIT $1.60
  • 52 Week High
  • COEP $13.70
  • CIIT $5.38
  • Technical
  • Relative Strength Index (RSI)
  • COEP 43.91
  • CIIT N/A
  • Support Level
  • COEP $6.80
  • CIIT N/A
  • Resistance Level
  • COEP $8.86
  • CIIT N/A
  • Average True Range (ATR)
  • COEP 0.62
  • CIIT 0.00
  • MACD
  • COEP -0.05
  • CIIT 0.00
  • Stochastic Oscillator
  • COEP 45.88
  • CIIT 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CIIT TIANCI INTERNATIONAL INC

Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.

Share on Social Networks: